Latest Ranbaxy Laboratories Limited Stories
PRINCETON, N.J., Nov. 5, 2014 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL) announced today that the Company has received approval from the U.S.
PRINCETON, N.J., Oct. 1, 2014 /PRNewswire/ -- Ranbaxy Laboratories Inc.
Receives first-to-file FDA approval, with 180-day marketing exclusivity for generic version in the treatment of hypertension and heart failure NEW BRUNSWICK, N.J., June 27, 2014 /PRNewswire/
The Corporate Whistleblower Center is encouraging all pharmaceutical insiders with proof of company involvement in manufacturing or distributing adulterated drugs to contact them at 866-714-6466